{"id":991,"date":"2026-04-09T12:28:58","date_gmt":"2026-04-09T12:28:58","guid":{"rendered":"https:\/\/thesporereport.com\/?p=991"},"modified":"2026-04-09T12:28:58","modified_gmt":"2026-04-09T12:28:58","slug":"an-international-mega-analysis-finds-that-every-psychedelic-affects-your-brain-the-same-way","status":"publish","type":"post","link":"https:\/\/thesporereport.com\/?p=991","title":{"rendered":"An International Mega-Analysis Finds That Every Psychedelic Affects Your Brain The Same Way"},"content":{"rendered":"\n

New research finds that psilocybin, LSD, ayahuasca, and mescaline all produce a surprisingly consistent signature in the brain. And it looks nothing like what scientists expected.<\/em><\/p>\n\n\n\n

A major new study<\/a> published in\u00a0Nature Medicine<\/em>\u00a0suggests that different psychedelic drugs have a strikingly similar effect on networks in the brain.<\/p>\n\n\n\n

Analysing over 500 brain scans from 267 participants across 11 studies, researchers identified a consistent “signature” pattern of neural activity shared across five different psychedelics: psilocybin, LSD, mescaline, DMT, and ayahuasca. <\/p>\n\n\n\n

The most comprehensive neuroimaging analysis of psychedelics conducted to date suggest that rather than breaking connections, these substances dramatically\u00a0increase<\/strong>\u00a0connectivity across the brain.<\/p>\n\n\n\n

\n\n\n\n

The common denominator<\/h2>\n\n\n\n

The research team, led by neuroscientist and AI researcher Danilo Bzdok at McGill University, developed a method for combining data across multiple imaging studies and tracking how activity in different brain regions fluctuates together over time. The consistency of what they found across chemically distinct substances surprised even them.<\/p>\n\n\n\n

“Despite the discrepancies in the pharmacology of these drugs, there is a common denominator of how they affect the human brain.”<\/p>\n\n\n\n

Under psychedelics, brain networks involved in advanced cognitive processing became far more interconnected than in sober baseline states. But that wasn’t all. Those same higher-order networks also showed dramatically increased coupling with regions responsible for processing vision and sound, and with areas that coordinate motor control. The boundaries that normally keep these systems operating somewhat independently appeared to soften significantly.<\/p>\n\n\n\n

There were also shifts in subcortical regions – deeper brain structures involved in perception, motivation, and reward. The effects, in other words, weren’t confined to the cortex or to any single system. They were distributed and, apparently, consistent.<\/p>\n\n\n\n

\n
Go Deeper<\/div>\n\n
The Spore Report<\/div>\n\n

If you’re interested in the evolving story of fungi, psychedelics, and nature’s intelligence, our weekly newsletter The Spore Report is worth your time.<\/p>\n\n Read The Spore Report \u2192<\/a>\n<\/div>\n\n\n\n

Why does this matter?<\/h2>\n\n\n\n

The practical implication cuts both ways. On one hand, this suggests that psilocybin, LSD, and ayahuasca may be producing their therapeutic effects through a shared neural pathway. That has significant implications for drug design. If you understand the common mechanism, you might be able to engineer compounds that hit that target more precisely, with fewer side effects or more predictable outcomes.<\/p>\n\n\n\n

On the other hand, it raises an uncomfortable question for how we categorise these substances. If psilocybin and mescaline produce the same brain signature despite being pharmacologically distinct, then the categories we’ve built around them – both legally and scientifically – may be somewhat arbitrary. The brain doesn’t appear to care much about the molecular differences we’ve used to draw those lines.<\/p>\n\n\n\n

\n

The Science<\/strong><\/em><\/p>\n\n\n\n

The study combined data from 11 neuroimaging datasets across the UK, Switzerland, the Netherlands, the US, and Brazil. Substances included psilocybin, LSD, mescaline, DMT, and ayahuasca. The paper<\/a> was published in\u00a0Nature Medicine\u00a0on 6 April 2026, authored by Girn et al.<\/em><\/p>\n<\/blockquote>\n\n\n\n

What this doesn’t settle<\/h2>\n\n\n\n

It’s worth being careful here. The researchers themselves flag important caveats. The studies combined in this analysis used different doses, different routes of administration, and scanned participants at different points after ingestion. These are meaningful variables, and drawing firm mechanistic conclusions from neuroimaging data is always tricky territory because brain connectivity patterns tell you something is happening, but not necessarily why or how at a molecular level.<\/p>\n\n\n\n

Psychiatrist Petros Petridis at NYU, who was not involved in the study, noted<\/a> that the approach enables more robust statistics and more reproducible findings in the future, while also cautioning against over-interpretation. Harvard’s Shan Siddiqi similarly called it a valuable first step toward correcting the historically small sample sizes that have made psychedelic neuroscience frustratingly inconclusive.<\/p>\n\n\n\n

This is, in short, a strong piece of evidence pointing in a clear direction. But it’s far from a closed case.<\/p>\n\n\n\n

\n\n\n\n

The bigger frame<\/h2>\n\n\n\n

The exciting thing about this finding is how well it maps onto a model of the mind that psychedelic researchers have been circling for years. And that’s the idea that the default, sober brain is not the neutral baseline we tend to assume it is. It’s a heavily pruned, efficiency-optimised state, where most possible connections between brain regions are actively suppressed in the service of focused, goal-directed function.<\/p>\n\n\n\n

Psychedelics, on this reading, don’t really create chaos. They temporarily relax that pruning or filtering. They restore degrees of connectivity that are normally held in check. Whether that’s experienced as mystical unity, visual distortion, or profound emotional openness may depend on set, setting, dose, and a dozen other factors. <\/p>\n\n\n\n

But the underlying mechanism, this research suggests, is remarkably consistant across substances.<\/p>\n\n\n\n

Source: Girn M. et al.,\u00a0Nature Medicine, 6 April 2026. doi: 10.1038\/s41591-026-04287-9<\/a><\/em><\/strong><\/p>\n\n\n\n

The Spore Report is a weekly newsletter that explores the science of fungi, regenerative biology, and what living systems can teach us about health.<\/em>\u00a0Sign up here.<\/a><\/em><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

New research finds that psilocybin, LSD, ayahuasca, and mescaline all produce a surprisingly consistent signature in the brain. And it looks nothing like what scientists expected. A major new study published in\u00a0Nature Medicine\u00a0suggests that different psychedelic drugs have a strikingly similar effect on networks in the brain. Analysing over 500 brain scans from 267 participants […]<\/p>\n","protected":false},"author":1,"featured_media":994,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"iawp_total_views":178,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-991","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/thesporereport.com\/index.php?rest_route=\/wp\/v2\/posts\/991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thesporereport.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thesporereport.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thesporereport.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thesporereport.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=991"}],"version-history":[{"count":3,"href":"https:\/\/thesporereport.com\/index.php?rest_route=\/wp\/v2\/posts\/991\/revisions"}],"predecessor-version":[{"id":995,"href":"https:\/\/thesporereport.com\/index.php?rest_route=\/wp\/v2\/posts\/991\/revisions\/995"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/thesporereport.com\/index.php?rest_route=\/wp\/v2\/media\/994"}],"wp:attachment":[{"href":"https:\/\/thesporereport.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=991"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thesporereport.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=991"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thesporereport.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}